Population pharmacokinetics of mycophenolic acid during the first week after renal transplantation von STAATZ, Christine E, DUFFULL, Stephen B, KIBERD, Bryce, FRASER, Albert D, TETT, Susan E

Volltext

Early Adequate Mycophenolic Acid Exposure is Associated with Less Rejection in Kidney Transplantation von Kiberd, Bryce A., Lawen, Joseph, Fraser, Albert D., Keough‐Ryan, Tammy, Belitsky, Philip

Volltext

Impact of lowering the screening and confirmation cutoff values for urine drug testing based on dilution indicators von FRASER, Albert D, ZAMECNIK, Jiri

Volltext

Effects of Fluid Load on Human Urine Characteristics Related to Workplace Drug Testing von Chaturvedi, Arvind K., Sershon, Jim L., Craft, Kristi J., Cardona, Patrick S., Soper, John W., Canfield, Dennis V., Dubowski, Kurt M., Whinnery, James E., Leyva, Misti J., Aston, Christopher E., Blevins, Steve M., Wright, Jonelle E., Fraser, Albert D., Kuntz, David J.

Volltext

Clinical toxicologic implications of ethylene glycol and glycolic acid poisoning von Fraser, Albert D

Volltext

Drug and chemical metabolites in clinical toxicology investigations: The importance of ethylene glycol, methanol and cannabinoid metabolite analyses von Fraser, Albert D, Coffin, Lawrence, Worth, David

Volltext

Monitoring urinary excretion of cannabinoids by fluorescence-polarization immunoassay: A cannabinoid-to-creatinine ratio study von FRASER, Albert D, WORTH, David

Volltext

A simple method to estimate the required dialysis time for cases of alcohol poisoning von Hirsch, David J., Jindal, Kailash K., Wong, Petula, Fraser, Albert D.

Volltext

Urinary excretion profiles of 11 -nor-9-carboxy-Δ9-tetrahydrocannabinol: a Δ9-THC-COOH to creatinine ratio study #2 von FRASER, Albert D, WORTH, David

Volltext

A 6-year experience with urine drug testing by family service agencies in Nova Scotia, Canada von Fraser, Albert D

Volltext

Substance abuse monitoring by the Correctional Service of Canada von FRASER, Albert D, ZAMECNIK, Jiri

Volltext

Comparative Evaluation of Five Immunoassays for the Analysis of Alprazolam and Triazolam Metabolites in Urine: Effect of Lowering the Screening and GC-MS Cut-Off Values von Fraser, Albert D., Meatherall, Robert

Volltext

Experience with a Urine Opiate Screening and Confirmation Cutoff of 2000 ng/mL von Fraser, Albert D, Worth, David

Volltext

Urinary excretion profiles of 11-nor-9-carboxy--THC: cannabinoid metabolites to creatinine ratio study IV von Fraser, Albert D, Worth, David

Volltext

Urinary excretion profiles of 11-nor-9-carboxy-delta9-tetrahydrocannabinol and 11-hydroxy-delta9-THC: cannabinoid metabolites to creatinine ratio study IV von Fraser, Albert D, Worth, David

Volltext

Urinary excretion profiles of 11-nor-9-carboxy-Δ9-tetrahydrocannabinol and 11-hydroxy-Δ9-THC: cannabinoid metabolites to creatinine ratio study IV von FRASER, Albert D, WORTH, David

Volltext

Urinary excretion profiles of 11-nor-9-carboxy-Δ 9-tetrahydrocannabinol and 11-hydroxy-Δ 9-THC: cannabinoid metabolites to creatinine ratio study IV von Fraser, Albert D, Worth, David

Volltext

Use and abuse of the benzodiazepines von FRASER, A. D

Volltext

Urinary excretion profiles of 11-nor-9-carboxy-Delta9-tetrahydrocannabinol. Study III. A Delta9-THC-COOH to creatinine ratio study von Fraser, Albert D, Worth, David

Volltext

Urinary excretion profiles of 11-nor-9-carboxy-Δ9-tetrahydrocannabinol von Fraser, Albert D., Worth, David

Volltext